BioSpace News Archive

BridgeBio Pharma, Inc. announced that on July 1, 2020, the compensation committee of BridgeBio’s board of directors granted eight employees options to purchase an aggregate of 7,120 shares of the Company’s common stock with a per share exercise price of $30.34 and restricted stock units for an aggregate of 15,134 shares of the Company’s common stock, including 1,610 performance-related restricted stock units.

– Supports the investigation of TransCon hGH for treatment of growth hormone deficiency in the pediatric population from 6 months to less than 18 years of age – – Company on track to submit European marketing application in third quarter 2020 – – No additional studies required – COPENHAGEN, Denmark, July 06, 2020 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND), a biopharmaceutical company that utilizes its innovative TransCon technologies to address unmet medical needs, tod

A-Medicare, the flagship private health services entrepreneurial enterprise of actor-producer Enzo Zelocchi, today announced launch plans for a new crypto coin as a planned element of early strategic growth integral to platform development through the remainder of 2020 and 2021.

CardieX Limited (ASX: CDX, CardieX, the Company) 100% subsidiary ATCOR has submitted a US patent application in regards to its recently announced wearable sensor technology (ASX: 24/04/2020).

Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced the start of a prospective, observational, global, multi-center, real-world, post-market study to evaluate the safety and effectiveness of the Valiant Navion™ Thoracic Stent Graft System in the treatment of thoracic aort

HOYA Corporation (TSE:7741, “HOYA”) and Hitachi, Ltd. (TSE:6501, “Hitachi”) today announced a five year contract regarding Endoscopic Ultrasound Systems [EUS] by which, i) the parties will strengthen technical collaboration, and ii) Hitachi will continue supplying diagnostic ultrasound systems and ultrasound sensor related parts used in EUS.

Deloitte has appointed Asif Dhar, M.D., to lead its life sciences and health care (LSHC) practice in the United States effective immediately.

Sharps Technology, Inc., today announced plans to manufacture its patented SHARPS PROVENSA™ smart safety syringes for use throughout the United States

Healthcare technology leader Axxess released a new comprehensive wound care management system that enables users to document and track wound care seamlessly.

Therap’s software now features a Health Screening tool for health care support professionals to document Screening Records and Recommendations as well as generate Health Screening Reports on individuals. Therap has designed the Health Screening forms according to the Age Group and Screening Recommendations listed in the Massachuset